Automatic Immunoassay analyzer HFIAS1000

Advantages

1.Easy to Use: simple operation

2.Fast: Read results in 4-8 minutes.

3.Less Maintenance: no liquid path, more efficient.

4.Portable and Compact: save space

Technical Parameters:

Sample Type: serum, plasma, whole blood, urine, etc.

Weight: about 2Kg

Size: 200mm * 190mm * 180mm (L * W* H)

Printing: built-in thermal printer

Interface: RS232 serial port, Ethernet port, USB interface

Repeatability: CV ≤15%

Stability: CV ≤ 8%

Ambient temperature: 10 ℃ ~ 30 ℃ (Note: the operating temperature of reagent shall be subject to the instruction)

Relative humidity: 10% ~ 70%

Power supply: voltage 1A / 115VAC 0.5A / 230VAC

Power frequency: 47 ~ 63Hz

Test Items:

Sex Hormone: β-HCG, Prog

Cardiovascular: Hs-cTnl, cTnl, 3in1 (Myo/CK-MB/cTnl), CK-MB+Myo， NT-proBNP, BNP

Inflammation: CRP、SAA、CRP+SAA， IL-6, PCT

Others: HbA1C, D-Dimer

E-mail: info@diacegene.com

website: 

http://www.xinchengbio.com/en/

Sichuan Xincheng Biological Co., Ltd. was founded in 2007, located in Chengdu High-tech Zone, Sichuan Province, P.R. China. It's a high-tech enterprise combined with R&D, production, sales of in vitro diagnostic (IVD) "instrument & reagent ", and provide" products & services ". The company was listed in the National Equities Exchange And Quotations(NEEQ) stock market on 2014, stock code 831193.



The company has a production base of 18.7 mu, building area of 24,000 m², the main products including automatic biochemical analyzer and supporting reagents, Point-of-care Testing(POCT) products, and more than 100 independent products. Xincheng BIO got quality management system certification of ISO9001、ISO13485, participates in the National Inter-room Quality Assessment Scheme to promote standardized traceability work.



As an in vitro diagnostic(IVD) products and services integrated program supplier, the future of Xincheng BIO will continue to adhere to the "customer-centered, teamwork, innovation, pragmatic, dedicated, progressive" core values, to be the innovator of IVD and the promoter of the general health care.